Last reviewed · How we verify
LGG Supplementation in Patients With AUD and ALD (AUD+ALD)
To test the efficacy of 6-month LGG compared to placebo in treating Alcoholic Use Disorder (AUD) and liver injury in Alcoholic Hepatitis (AH). And to evaluate the effects of LGG treatment compared to placebo on therapeutic-mechanistic markers of the gut-brain axis and pro-inflammatory activity in patients with AUD and moderate AH
Details
| Lead sponsor | University of Louisville |
|---|---|
| Phase | PHASE2 |
| Status | RECRUITING |
| Enrolment | 60 |
| Start date | Wed Jun 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sun Feb 28 2027 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Alcohol Use Disorder
- Alcohol-associated Liver Disease
Interventions
- : Placebo for Probiotic
- Lactobacillus Rhamnosus GG
Countries
United States